These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 10536005)

  • 21. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
    Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
    Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector.
    Reddy PS; Sakhuja K; Ganesh S; Yang L; Kayda D; Brann T; Pattison S; Golightly D; Idamakanti N; Pinkstaff A; Kaloss M; Barjot C; Chamberlain JS; Kaleko M; Connelly S
    Mol Ther; 2002 Jan; 5(1):63-73. PubMed ID: 11786047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery.
    O'Neal WK; Zhou H; Morral N; Aguilar-Cordova E; Pestaner J; Langston C; Mull B; Wang Y; Beaudet AL; Lee B
    Hum Gene Ther; 1998 Jul; 9(11):1587-98. PubMed ID: 9694157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration.
    McClane SJ; Chirmule N; Burke CV; Raper SE
    Hum Gene Ther; 1997 Dec; 8(18):2207-16. PubMed ID: 9449374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.
    Oka K; Belalcazar LM; Dieker C; Nour EA; Nuno-Gonzalez P; Paul A; Cormier S; Shin JK; Finegold M; Chan L
    Gene Ther; 2007 Feb; 14(3):191-202. PubMed ID: 16957769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
    Song W; Kong HL; Traktman P; Crystal RG
    Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.
    Brunetti-Pierri N; Palmer DJ; Beaudet AL; Carey KD; Finegold M; Ng P
    Hum Gene Ther; 2004 Jan; 15(1):35-46. PubMed ID: 14965376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges.
    Vetrini F; Ng P
    Curr Pharm Des; 2011; 17(24):2488-99. PubMed ID: 21774769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal vaccination with a helper-dependent adenoviral vector enhances transgene-specific immune responses in BALB/c mice.
    Fu YH; He JS; Zheng XX; Wang XB; Xie C; Shi CX; Zhang M; Tang Q; Wei W; Qu JG; Hong T
    Biochem Biophys Res Commun; 2010 Jan; 391(1):857-61. PubMed ID: 19945423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors.
    Brunetti-Pierri N; Ng T; Iannitti D; Cioffi W; Stapleton G; Law M; Breinholt J; Palmer D; Grove N; Rice K; Bauer C; Finegold M; Beaudet A; Mullins C; Ng P
    Hum Gene Ther; 2013 Aug; 24(8):761-5. PubMed ID: 23902403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helper-dependent adenoviral vectors for liver-directed gene therapy.
    Brunetti-Pierri N; Ng P
    Hum Mol Genet; 2011 Apr; 20(R1):R7-13. PubMed ID: 21470977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
    Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
    Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system.
    Zou L; Zhou H; Pastore L; Yang K
    Mol Ther; 2000 Aug; 2(2):105-13. PubMed ID: 10947937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration.
    Nunes FA; Furth EE; Wilson JM; Raper SE
    Hum Gene Ther; 1999 Oct; 10(15):2515-26. PubMed ID: 10543616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of helper-dependent adenoviral vectors by homologous recombination.
    Toietta G; Pastore L; Cerullo V; Finegold M; Beaudet AL; Lee B
    Mol Ther; 2002 Feb; 5(2):204-10. PubMed ID: 11829528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of the generation and propagation of gutless adenoviral vectors.
    Sakhuja K; Reddy PS; Ganesh S; Cantaniag F; Pattison S; Limbach P; Kayda DB; Kadan MJ; Kaleko M; Connelly S
    Hum Gene Ther; 2003 Feb; 14(3):243-54. PubMed ID: 12639304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gutless adenovirus: last-generation adenovirus for gene therapy.
    Alba R; Bosch A; Chillon M
    Gene Ther; 2005 Oct; 12 Suppl 1():S18-27. PubMed ID: 16231052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.
    Croyle MA; Chirmule N; Zhang Y; Wilson JM
    Hum Gene Ther; 2002 Oct; 13(15):1887-900. PubMed ID: 12396620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
    Ilan Y; Prakash R; Davidson A; Jona ; Droguett G; Horwitz MS; Chowdhury NR; Chowdhury JR
    J Clin Invest; 1997 Mar; 99(5):1098-106. PubMed ID: 9062369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy.
    Lamartina S; Cimino M; Roscilli G; Dammassa E; Lazzaro D; Rota R; Ciliberto G; Toniatti C
    J Gene Med; 2007 Oct; 9(10):862-74. PubMed ID: 17685494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.